Translational Studies Using the MALT1 Inhibitor ( S )-Mepazine to Induce Treg Fragility and Potentiate Immune Checkpoint Therapy in Cancer.

Mauro Di PilatoYun GaoYi SunAmina FuCarina GrassThomas SeeholzerRegina FeederleIrina MazoSamuel W KazerKevin LitchfieldUlrich H von AndrianThorsten R MempelRussell W JenkinsDaniel KrappmannPeter Keller

Published in: Journal of immunotherapy and precision oncology (2023)

)-mepazine succinate, in patients with advanced or metastatic treatment-refractory solid tumors.

Keyphrases

squamous cell carcinoma
papillary thyroid
small cell lung cancer
squamous cell
young adults
lymph node metastasis
case control
childhood cancer
cell therapy
hip fracture